Jeroen Pollet

Assistant Professor

Baylor College of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Jeroen Pollet is an Assistant Professor at Baylor College of Medicine in the United States. His research focuses on vaccine development and cellular responses to various pathogens, including hookworm, norovirus, and SARS-CoV-2. Recent publications highlight his work on mRNA vaccine candidates and novel strategies for enhancing immune responses against infectious diseases.

Articles (22)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

UNITED STATES

View details

Laura-Isobel McCall

University of Oklahoma

UNITED STATES

View details

Katharine Floyd

Emory University

UNITED STATES

View details

Bibiana Petri da Silveira

Texas A&M University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeroen Pollet

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

Altering the intracellular trafficking of Necator americanus GST-1 antigen yields novel hookworm mRNA vaccine candidates

Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins

RNA-dependent RNA polymerase of predominant human norovirus forms liquid-liquid phase condensates as viral replication factories

Multi-Antigen Elephant Endotheliotropic Herpesvirus (EEHV) mRNA Vaccine Induces Humoral and Cell-Mediated Responses in Mice

From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access.

Equine bronchial epithelial cells are susceptible to cell entry with a SARS-CoV-2 pseudovirus but reveal low replication efficiency

Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8+ T-cells

DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors

A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2

Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease

The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection

Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

A novel multi-epitope recombinant protein elicits an antigen-specific CD8+ T cells response in Trypanosoma cruzi-infected mice

A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates

Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi

DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M pro inhibitors

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice

Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate

Recombinant protein vaccines, a proven approach against coronavirus pandemics

Safe and effective aerosolization of in vitro transcribed mRNA to the respiratory tract epithelium of horses without a transfection agent

Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection

Collaborators (9)

Jason Kimata

Cristina Poveda

Rebecca Legere

Srinivas Chamakuri

Feng Li

John Faver

Laura-Isobel McCall

Katharine Floyd

Bibiana Petri da Silveira

Make your next move.